Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2017-05-05
Target enrollment:
Participant gender:
Summary
The aim of the present study is to evaluate the effect of increasing the proportion of
D-chiro-inositol (DCI) in a combination with myo-inositol (MYO) in improving fertility in
women with polycystic ovarian syndrome (PCOS). Sixty women diagnosed with PCOS will randomly
take twice a day for 12 weeks a capsule containing 550 mg of myo-inositol and 150 mg of
D-chiro-inositol or capsules containing 550 mg of myo-inositol and 13.8 mg of
D-chiro-inositol.